The DOI matches its Crossref record; 82 of the 83 references it cites were found in a registry or an index.
Prevalence and Characteristics of Adrenal Tumors and Myelolipomas in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
Open accessAbstract
Objective The prevalence of adrenal tumors in congenital adrenal hyperplasia (CAH) is uncertain. Our objective was to estimate the prevalence and characteristics of adrenal tumors and myelolipoma in CAH, and investigate clinical features of this population.Methods We carried out systematic searches in Medline Ovid and Embase for articles published until January, 2020. Studies with confirmed CAH, biochemically and/or genetically, were included. The two authors independently extracted data from each study.Results Six cohort studies were included in the prevalence calculation. In addition, 32 case reports on adrenal myelolipomas and CAH were included. The prevalence of adrenal tumors in CAH was 29.3%. When only studies with genetically verified cytochrome P450, Family 21, subfamily A, polypeptide 2 gene (CYP21A2) mutations were included the prevalence was 23.6%. The prevalence of myelolipoma in CAH was 7.4% (verified CYP21A2 mutations 8.6%). The proportion of myelolipoma in the adrenal tumors was 25.4% (genetically verified 36.6%). The median (range) age at tumor diagnosis was 36.0 (12 to 60) years and there were more tumors in males than in females (37.9% versus 22.1%; P<.05). In patients with myelolipomas, 93.5% had an undiagnosed or poorly managed CAH.Conclusion Patients with CAH had a high prevalence of adrenal tumors, particularly myelolipomas. Those with myelolipomas had a high frequency of late-diagnosed or poorly controlled CAH. Adrenal imaging may be considered in patients with CAH, especially if abdominal pain is present.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These differences may be due to both glucocorticoid and androgen exposure, since androgens stimulate osteoblast proliferation and differentiation in both genders (723).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [723]
In the citing paper
“Adrenal hyperplasia and nodularity are commonly seen in patients with CAH, with a high prevalence of benign adrenal tumours (29%) and myelolipomas (8.6%)93.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [93]
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Song, J. H., Chaudhry, F. S., & Mayo-Smith, W. W. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.07.2799 · Cited by 579
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
PW, S., W, A., RJ, A., LS, B., GS, C., DP, M., HFL, M.-B., WL, M., MH, M., SE, O., et al. (2019) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.16.8.5 · Cited by 300
Myelolipoma: CT and pathologic features.
Kenney, P. J., Wagner, B. J., Rao, P., & Heffess, C. S. (1998) · Radiology · doi:10.1148/radiology.208.1.9646797 · Cited by 287
Rushworth, R. L., Torpy, D. J., & Falhammar, H. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1807486 · Cited by 262
Self-citationSteroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic
Auchus, R. J. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.002 · Cited by 229
Research works printed but not linked: 2
- Iwamoto, 1993, A case report: reversible male infertility due to congenital adrenal hyperplasia [in Japanese], Nippon Hinyokika Gakkai Zasshi., 84, 2031
- Treska, 2006, Giant bilateral adrenal myelolipoma associated with congenital adrenal hyperplasia [in German], Zentralbl Chir., 131, 80
Cited by
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationOverview of the 2022 WHO Classification of Adrenal Cortical Tumors
Mete, O., Erickson, L. A., Juhlin, C. C., de Krijger, R. R., Sasano, H., Volante, M., & Papotti, M. G. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09710-8 · Cited by 343
Management challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
Calissendorff, J., Juhlin, C. C., Sundin, A., Bancos, I., & Falhammar, H. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00178-9 · Cited by 125
Self-citationGenetic control of typical and atypical sex development
Reyes, A. P., León, N. Y., Frost, E. R., & Harley, V. R. (2023) · Nature Reviews Urology · doi:10.1038/s41585-023-00754-x · Cited by 63
Metadata
- Authors
- Nermoen, I., & Falhammar, H.
- Affiliations
- University of Oslo (NO)
- Karolinska University Hospital (SE)
- Corresponding author
- Nermoen, Ingrid
- Venue
- Endocrine Practice
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 26
- Issue
- 11
- Pages
- 1351-1365
- ISSN
- 1530-891X (ISSN-L)
- OpenAlex
- W3017951906
- Cited by
- 66
- References
- 83
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 14 · 2023: 11 · 2022: 10 · 2021: 11
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- green
- urn.nb.no
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Endocrine Practice (publishedVersion)
- PubMed (publishedVersion)
- Duo Research Archive (University of Oslo) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- congenital adrenal hyperplasia, adrenal tumors, adrenal myelolipoma, CYP21A2 mutations, prevalence, delayed diagnosis, adrenal imaging, abdominal pain, sex differences
- MeSH terms
- Adrenal Gland Neoplasms, Adrenal Hyperplasia, Congenital, Adult, Female, Humans, Male, Middle Aged, Steroid 21-Hydroxylase, Tomography, X-Ray Computed, Prevalence, Myelolipoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence and Characteristics of Adrenal Tumors and Myelolipomas in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.4158/ep-2020-0058
- The paper
- Nermoen, I., & Falhammar, H. (2020). Prevalence and Characteristics of Adrenal Tumors and Myelolipomas in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis. Endocrine Practice. https://doi.org/10.4158/ep-2020-0058
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.